Stocklytics Platform
Asset logo for symbol ILMN
Asset logo for symbol ILMN


Key Stats
Prev. Close$115.79
Next Earnings Date-
Dividend Yield %-
PE Ratio-
Day Range113.32
52 Week Range86.57
Payout Ratio-
Industry average yield2.92%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis


Summarizing what the indicators are suggesting.

Strong Buy
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Strong Sell

Stock Performance

US Healthcare Sectorarrow_drop_up0.04%
US Marketarrow_drop_up0.79%
ILMN / Market
ILMN lose to the US Market which returned 0.79% over the last twenty four hours.
ILMN / Healthcare Sector
ILMN lose to the US Healthcare sector which returned 0.04% over the last twenty four hours.

Illumina (ILMN) Statistics

Statistics for Illumina Inc, ILMN stock highlight key metrics and performance indicators for investors. Valuation metrics provide insights into the company's market worth and potential. Illumina Inc is a leading provider of genetic sequencing solutions, and its stock statistics offer valuable information. The company's fundamentals, such as revenue, profit margins, and total debt, further contribute to understanding its financial health. Evaluating Illumina Inc's stock performance relative to its sector helps investors assess its competitiveness and market position. Additionally, revenue per share and gross profit metrics provide a comprehensive view of the company's financial performance. The CEO of Illumina Inc plays a crucial role in driving the company's growth and strategic initiatives.

Illumina Inc, ILMN has established itself as a dominant player in the genetic sequencing industry. As of the latest available data, Illumina Inc stock has shown remarkable performance, outperforming its sector by a significant margin. This positive trend has resulted in a strong valuation, as represented by various metrics. The enterprise to EBITDA ratio reflects the company's profitability and efficiency in generating earnings before interest, taxes, depreciation, and amortization. Illumina Inc's impressive profit margin indicates its ability to generate profits from its operations. Moreover, the company has managed its debt effectively, resulting in a healthy balance sheet. The gross profit metric showcases the company's ability to generate revenue after deducting the cost of goods sold. Overall, the CEO of Illumina Inc plays a pivotal role in driving the company's success and delivering value to its shareholders.

add Illumina  to watchlist

Keep an eye on Illumina

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

How has Illumina (ILMN) stock's performance compared to its sector and the market over the past year?

Over the past year, Illumina (ILMN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.12%, Illumina has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.49%, it has fallen short of the market average. This comparison highlights Illumina 's performance relative to both its sector and the overall market over the last year.

What is the PE ratio of Illumina (ILMN) stock?

The PE ratio for Illumina (ILMN) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

What is the EPS of Illumina (ILMN) stock?

The Earnings Per Share (EPS) for Illumina (ILMN), calculated on a diluted basis, is -$8.15. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

What is the operating margin of Illumina (ILMN) stock?

The operating margin for Illumina (ILMN) is -5.48%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

What is the EBITDA of Illumina (ILMN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Illumina (ILMN) is $234M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

How much debt does Illumina (ILMN) have?

Illumina (ILMN) has a total debt of $2.28B. The net debt, which accounts for cash and cash equivalents against the total debt, is $1.17B.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level